Magnesium in PDB 5cz9: Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Enzymatic activity of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
All present enzymatic activity of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans:
3.4.25.1;
Protein crystallography data
The structure of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans, PDB code: 5cz9
was solved by
E.M.Huber,
M.Groll,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
15.00 /
2.90
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.720,
300.900,
145.070,
90.00,
112.94,
90.00
|
R / Rfree (%)
|
19.9 /
22.3
|
Other elements in 5cz9:
The structure of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
(pdb code 5cz9). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 7 binding sites of Magnesium where determined in the
Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans, PDB code: 5cz9:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
6;
7;
Magnesium binding site 1 out
of 7 in 5cz9
Go back to
Magnesium Binding Sites List in 5cz9
Magnesium binding site 1 out
of 7 in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
G:Mg301
b:41.1
occ:1.00
|
O
|
G:MET125
|
2.3
|
39.1
|
1.0
|
O
|
G:ARG122
|
2.5
|
37.9
|
1.0
|
OG1
|
G:THR8
|
2.6
|
35.6
|
1.0
|
O
|
G:TYR119
|
2.7
|
30.4
|
1.0
|
CG2
|
G:THR8
|
3.2
|
37.8
|
1.0
|
O
|
G:ALA123
|
3.3
|
44.1
|
1.0
|
C
|
G:MET125
|
3.4
|
39.2
|
1.0
|
CB
|
G:THR8
|
3.5
|
37.1
|
1.0
|
C
|
G:ARG122
|
3.6
|
39.5
|
1.0
|
C
|
G:ALA123
|
3.7
|
41.4
|
1.0
|
CA
|
G:ALA123
|
3.7
|
40.0
|
1.0
|
C
|
G:TYR119
|
3.9
|
31.6
|
1.0
|
N
|
G:ALA123
|
4.1
|
38.9
|
1.0
|
N
|
G:THR8
|
4.1
|
40.5
|
1.0
|
CA
|
G:ARG126
|
4.2
|
34.8
|
1.0
|
N
|
G:ARG126
|
4.3
|
36.6
|
1.0
|
N
|
G:MET125
|
4.3
|
41.1
|
1.0
|
CA
|
G:MET125
|
4.4
|
43.3
|
1.0
|
CA
|
G:THR8
|
4.4
|
38.8
|
1.0
|
CD
|
G:PRO127
|
4.6
|
31.2
|
1.0
|
CA
|
G:TYR119
|
4.6
|
31.2
|
1.0
|
N
|
G:TYR124
|
4.6
|
43.2
|
1.0
|
N
|
G:THR120
|
4.9
|
31.9
|
1.0
|
C
|
G:ARG126
|
4.9
|
34.0
|
1.0
|
CA
|
G:ARG122
|
4.9
|
41.8
|
1.0
|
N
|
G:ARG122
|
5.0
|
38.9
|
1.0
|
CA
|
G:THR120
|
5.0
|
32.0
|
1.0
|
C
|
G:TYR124
|
5.0
|
40.8
|
1.0
|
|
Magnesium binding site 2 out
of 7 in 5cz9
Go back to
Magnesium Binding Sites List in 5cz9
Magnesium binding site 2 out
of 7 in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:Mg301
b:48.4
occ:1.00
|
O
|
I:ASP177
|
2.6
|
50.8
|
1.0
|
O
|
I:ALA174
|
2.9
|
53.0
|
1.0
|
O
|
I:SER180
|
2.9
|
48.3
|
1.0
|
OXT
|
I:ASP204
|
3.5
|
72.9
|
1.0
|
C
|
I:ASP177
|
3.7
|
48.5
|
1.0
|
C
|
I:ALA174
|
4.0
|
51.8
|
1.0
|
C
|
I:SER180
|
4.1
|
47.8
|
1.0
|
CA
|
I:ASP175
|
4.2
|
53.2
|
1.0
|
O
|
I:ALA178
|
4.3
|
56.0
|
1.0
|
CA
|
I:ALA178
|
4.3
|
49.5
|
1.0
|
O
|
I:ASP204
|
4.3
|
73.4
|
1.0
|
C
|
I:ASP204
|
4.3
|
72.3
|
1.0
|
NH2
|
Y:ARG19
|
4.4
|
72.0
|
1.0
|
C
|
I:ALA178
|
4.4
|
51.2
|
1.0
|
N
|
I:ALA178
|
4.4
|
47.4
|
1.0
|
C
|
I:ASP175
|
4.5
|
51.9
|
1.0
|
O
|
I:ASP175
|
4.5
|
52.2
|
1.0
|
N
|
I:ASP175
|
4.6
|
51.8
|
1.0
|
N
|
I:ASP177
|
4.6
|
48.9
|
1.0
|
CA
|
I:ASP177
|
4.7
|
48.7
|
1.0
|
N
|
I:SER180
|
4.8
|
46.4
|
1.0
|
NH1
|
Y:ARG19
|
4.9
|
74.2
|
1.0
|
CA
|
I:GLY181
|
4.9
|
47.5
|
1.0
|
N
|
I:GLY181
|
5.0
|
46.8
|
1.0
|
CZ
|
Y:ARG19
|
5.0
|
71.2
|
1.0
|
|
Magnesium binding site 3 out
of 7 in 5cz9
Go back to
Magnesium Binding Sites List in 5cz9
Magnesium binding site 3 out
of 7 in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:Mg302
b:48.0
occ:1.00
|
O
|
Y:ASP168
|
2.3
|
53.3
|
1.0
|
O
|
I:ASP204
|
2.4
|
73.4
|
1.0
|
O
|
Y:ALA165
|
2.5
|
49.8
|
1.0
|
O
|
Y:SER171
|
2.9
|
54.6
|
1.0
|
C
|
I:ASP204
|
3.1
|
72.3
|
1.0
|
C
|
Y:ASP168
|
3.3
|
52.4
|
1.0
|
CA
|
Y:ALA169
|
3.6
|
53.2
|
1.0
|
O
|
Y:HIS166
|
3.6
|
49.5
|
1.0
|
C
|
Y:ALA165
|
3.7
|
51.5
|
1.0
|
CA
|
I:ASP204
|
3.7
|
71.0
|
1.0
|
NH1
|
Y:ARG19
|
3.7
|
74.2
|
1.0
|
O
|
Y:ALA169
|
3.8
|
53.1
|
1.0
|
N
|
Y:ALA169
|
3.8
|
52.7
|
1.0
|
C
|
Y:ALA169
|
3.9
|
52.5
|
1.0
|
OXT
|
I:ASP204
|
4.0
|
72.9
|
1.0
|
C
|
Y:HIS166
|
4.1
|
51.7
|
1.0
|
C
|
Y:SER171
|
4.1
|
54.6
|
1.0
|
CB
|
I:ASP204
|
4.1
|
72.3
|
1.0
|
N
|
Y:ASP168
|
4.5
|
51.6
|
1.0
|
CA
|
Y:ASP168
|
4.5
|
51.7
|
1.0
|
CA
|
Y:HIS166
|
4.5
|
52.0
|
1.0
|
N
|
Y:HIS166
|
4.5
|
50.9
|
1.0
|
N
|
Y:SER171
|
4.5
|
52.8
|
1.0
|
CA
|
Y:ALA165
|
4.6
|
52.7
|
1.0
|
C
|
Y:ARG167
|
4.6
|
51.5
|
1.0
|
O
|
Y:ALA164
|
4.8
|
50.2
|
1.0
|
N
|
Y:ARG167
|
4.8
|
51.0
|
1.0
|
N
|
Y:TYR170
|
4.8
|
52.8
|
1.0
|
CZ
|
Y:ARG19
|
4.8
|
71.2
|
1.0
|
O
|
Y:ARG167
|
4.8
|
50.5
|
1.0
|
CA
|
Y:SER171
|
4.9
|
53.0
|
1.0
|
CB
|
Y:ALA169
|
4.9
|
54.0
|
1.0
|
|
Magnesium binding site 4 out
of 7 in 5cz9
Go back to
Magnesium Binding Sites List in 5cz9
Magnesium binding site 4 out
of 7 in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
K:Mg302
b:41.0
occ:1.00
|
O
|
K:ASP168
|
2.0
|
51.3
|
1.0
|
O
|
K:ALA165
|
2.4
|
50.8
|
1.0
|
O
|
W:ASP204
|
2.6
|
66.0
|
1.0
|
O
|
K:SER171
|
2.8
|
53.3
|
1.0
|
C
|
K:ASP168
|
3.1
|
52.3
|
1.0
|
C
|
W:ASP204
|
3.3
|
63.4
|
1.0
|
C
|
K:ALA165
|
3.5
|
52.0
|
1.0
|
CA
|
K:ALA169
|
3.6
|
53.8
|
1.0
|
O
|
K:HIS166
|
3.6
|
49.8
|
1.0
|
CA
|
W:ASP204
|
3.7
|
62.9
|
1.0
|
N
|
K:ALA169
|
3.7
|
52.7
|
1.0
|
O
|
K:ALA169
|
3.8
|
52.3
|
1.0
|
NH1
|
K:ARG19
|
3.8
|
66.7
|
1.0
|
C
|
K:ALA169
|
3.8
|
54.0
|
1.0
|
C
|
K:HIS166
|
4.0
|
51.5
|
1.0
|
C
|
K:SER171
|
4.0
|
54.5
|
1.0
|
CB
|
W:ASP204
|
4.2
|
63.4
|
1.0
|
OXT
|
W:ASP204
|
4.2
|
60.1
|
1.0
|
N
|
K:ASP168
|
4.2
|
52.2
|
1.0
|
CA
|
K:ASP168
|
4.3
|
52.6
|
1.0
|
N
|
K:HIS166
|
4.4
|
51.0
|
1.0
|
N
|
K:SER171
|
4.4
|
51.5
|
1.0
|
CA
|
K:HIS166
|
4.4
|
51.7
|
1.0
|
CA
|
K:ALA165
|
4.5
|
52.9
|
1.0
|
C
|
K:ARG167
|
4.5
|
51.9
|
1.0
|
O
|
K:ALA164
|
4.5
|
51.0
|
1.0
|
N
|
K:ARG167
|
4.6
|
50.9
|
1.0
|
N
|
K:TYR170
|
4.7
|
54.0
|
1.0
|
O
|
K:ARG167
|
4.7
|
51.8
|
1.0
|
CA
|
K:SER171
|
4.7
|
52.5
|
1.0
|
CZ
|
K:ARG19
|
4.9
|
66.4
|
1.0
|
CB
|
K:ALA169
|
4.9
|
54.3
|
1.0
|
|
Magnesium binding site 5 out
of 7 in 5cz9
Go back to
Magnesium Binding Sites List in 5cz9
Magnesium binding site 5 out
of 7 in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Mg301
b:61.8
occ:1.00
|
OXT
|
L:ASP222
|
2.1
|
74.5
|
1.0
|
O
|
V:ILE163
|
2.3
|
48.6
|
1.0
|
O
|
V:ASP166
|
2.4
|
40.5
|
1.0
|
C
|
L:ASP222
|
3.0
|
71.5
|
1.0
|
O
|
V:SER169
|
3.2
|
40.2
|
1.0
|
C
|
V:ASP166
|
3.2
|
42.4
|
1.0
|
O
|
V:TRP164
|
3.4
|
51.4
|
1.0
|
C
|
V:ILE163
|
3.4
|
49.3
|
1.0
|
CA
|
L:ASP222
|
3.6
|
67.1
|
1.0
|
C
|
V:TRP164
|
3.6
|
49.2
|
1.0
|
N
|
V:LEU167
|
3.8
|
43.0
|
1.0
|
O
|
L:ASP222
|
3.9
|
72.6
|
1.0
|
CA
|
V:LEU167
|
3.9
|
43.6
|
1.0
|
N
|
V:ASP166
|
3.9
|
42.0
|
1.0
|
O
|
V:GLY162
|
4.0
|
49.0
|
1.0
|
CA
|
V:TRP164
|
4.0
|
49.1
|
1.0
|
N
|
V:TRP164
|
4.1
|
49.0
|
1.0
|
CA
|
V:ASP166
|
4.2
|
42.2
|
1.0
|
N
|
V:ASN165
|
4.2
|
46.9
|
1.0
|
C
|
V:SER169
|
4.3
|
42.7
|
1.0
|
CB
|
L:ASP222
|
4.4
|
65.2
|
1.0
|
O
|
L:ARG221
|
4.4
|
59.6
|
1.0
|
C
|
V:ASN165
|
4.4
|
43.2
|
1.0
|
NH1
|
V:ARG19
|
4.4
|
57.5
|
1.0
|
CA
|
V:ILE163
|
4.4
|
49.6
|
1.0
|
C
|
V:LEU167
|
4.5
|
43.4
|
1.0
|
CD2
|
V:LEU167
|
4.6
|
43.2
|
1.0
|
N
|
L:ASP222
|
4.7
|
63.6
|
1.0
|
CA
|
V:ASN165
|
4.8
|
45.3
|
1.0
|
O
|
V:LEU167
|
4.8
|
44.7
|
1.0
|
CD1
|
L:ILE35
|
4.9
|
52.6
|
1.0
|
N
|
V:SER169
|
5.0
|
43.3
|
1.0
|
|
Magnesium binding site 6 out
of 7 in 5cz9
Go back to
Magnesium Binding Sites List in 5cz9
Magnesium binding site 6 out
of 7 in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 6 of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
N:Mg202
b:44.0
occ:1.00
|
O
|
N:SER169
|
2.5
|
36.5
|
1.0
|
O
|
N:ILE163
|
2.8
|
39.1
|
1.0
|
O
|
N:ASP166
|
3.0
|
38.5
|
1.0
|
NH1
|
N:ARG19
|
3.4
|
40.0
|
1.0
|
C
|
N:SER169
|
3.7
|
35.2
|
1.0
|
CD1
|
a:LEU34
|
3.8
|
40.5
|
1.0
|
C
|
N:ILE163
|
3.9
|
38.5
|
1.0
|
CZ
|
N:ARG19
|
4.1
|
38.2
|
1.0
|
C
|
N:ASP166
|
4.1
|
37.3
|
1.0
|
CG2
|
N:ILE163
|
4.1
|
37.2
|
1.0
|
CA
|
N:GLY167
|
4.2
|
37.4
|
1.0
|
CA
|
N:GLY170
|
4.3
|
36.8
|
1.0
|
O
|
N:GLY167
|
4.3
|
37.1
|
1.0
|
NH2
|
N:ARG19
|
4.3
|
38.4
|
1.0
|
N
|
N:GLY170
|
4.4
|
36.0
|
1.0
|
C
|
N:GLY167
|
4.5
|
36.5
|
1.0
|
CA
|
N:ILE163
|
4.6
|
37.2
|
1.0
|
N
|
N:GLY167
|
4.6
|
37.2
|
1.0
|
N
|
N:SER169
|
4.7
|
33.8
|
1.0
|
CA
|
N:SER169
|
4.8
|
33.1
|
1.0
|
CB
|
N:ILE163
|
5.0
|
36.5
|
1.0
|
N
|
N:LYS164
|
5.0
|
38.9
|
1.0
|
|
Magnesium binding site 7 out
of 7 in 5cz9
Go back to
Magnesium Binding Sites List in 5cz9
Magnesium binding site 7 out
of 7 in the Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 7 of Yeast 20S Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Z:Mg301
b:50.1
occ:1.00
|
O
|
Z:VAL198
|
2.5
|
50.6
|
1.0
|
O
|
Z:THR192
|
2.7
|
54.9
|
1.0
|
O
|
Z:HIS195
|
3.0
|
44.3
|
1.0
|
O
|
Z:ASP222
|
3.4
|
66.1
|
1.0
|
NH2
|
Z:ARG28
|
3.6
|
58.3
|
1.0
|
CG2
|
Z:THR192
|
3.6
|
56.4
|
1.0
|
C
|
Z:THR192
|
3.7
|
56.5
|
1.0
|
C
|
Z:VAL198
|
3.7
|
50.7
|
1.0
|
O
|
Z:ILE196
|
4.0
|
44.8
|
1.0
|
CA
|
Z:THR192
|
4.1
|
56.0
|
1.0
|
C
|
Z:HIS195
|
4.1
|
45.9
|
1.0
|
CA
|
Z:ILE196
|
4.2
|
45.2
|
1.0
|
OD1
|
Z:ASP222
|
4.2
|
63.5
|
1.0
|
C
|
Z:ILE196
|
4.3
|
43.5
|
1.0
|
NH2
|
H:ARG19
|
4.4
|
60.0
|
1.0
|
CB
|
Z:THR192
|
4.5
|
56.7
|
1.0
|
C
|
Z:ASP222
|
4.5
|
65.5
|
1.0
|
N
|
Z:VAL198
|
4.5
|
47.5
|
1.0
|
CA
|
Z:GLY199
|
4.6
|
51.5
|
1.0
|
N
|
Z:GLY199
|
4.6
|
51.2
|
1.0
|
CZ
|
Z:ARG28
|
4.6
|
56.3
|
1.0
|
N
|
Z:ILE196
|
4.6
|
45.4
|
1.0
|
CA
|
Z:VAL198
|
4.7
|
49.1
|
1.0
|
NH1
|
Z:ARG28
|
4.8
|
59.6
|
1.0
|
O
|
Z:LYS220
|
4.9
|
59.3
|
1.0
|
N
|
Z:GLU193
|
4.9
|
55.8
|
1.0
|
|
Reference:
E.M.Huber,
W.Heinemeyer,
X.Li,
C.S.Arendt,
M.Hochstrasser,
M.Groll.
A Unified Mechanism For Proteolysis and Autocatalytic Activation in the 20S Proteasome. Nat Commun V. 7 10900 2016.
ISSN: ESSN 2041-1723
PubMed: 26964885
DOI: 10.1038/NCOMMS10900
Page generated: Sun Sep 29 02:21:15 2024
|